Finding the Right Expertise in Potent Drug Contract Manufacturing

The highly-potent drug contract manufacturing industry continues to grow annually. The market for HPAPIs (highly potent active pharmaceutical ingredients), such as prostaglandins, anti-cancer drugs, opioids, and hormones, has a very high value.

Producing highly potent compounds involves extremely intricate, pricey facilities and processes. The compounds also come with high risks of contamination and toxicity. Because of these concerns, many pharmaceutical companies are partnering with contract manufacturing organizations. However, partnering with CMOs isn’t all it takes; finding the right expertise is the most important.

Handling Highly Potent Active Pharmaceutical Ingredients

Handling high potency active pharmaceutical ingredient formulations requires excellent and meticulous attention to detail, outstanding training, and a great understanding of the risks at every step of the manufacturing process.

This means that pharmaceutical manufacturing companies must take extreme care when choosing their contract manufacturing organization to partner with for HPAPI production. This is crucial to ensure that they are partnering with organizations that provide the best expertise.

There are many Positive Market Indicators in Potent Drug Contract Manufacturing

One of the top categories of high potency active pharmaceutical ingredients is oncology drugs. These drugs were already the most-valued therapeutic class of drugs in 2007. Here, $41.4 billion was accounted for, about 6.2 percent of the total global pharmaceutical market.

The sales of anti-cancer drugs such as cytotoxic active pharmaceutical ingredients have gone beyond double since then. About sixty percent of all the high-potency active pharmaceutical ingredients currently under development are focused on the cure of cancer.

However, cancer treatments are only a part of high-potency compound production. One of the most predominant trends in modern medicine is a slow but steady shift towards more potent, targeted treatments, which are biologically active in slight amounts. These treatments include lipids such as prostaglandins, therapeutic hormones, pain medicines such as opioids, and other highly potent active pharmaceutical ingredients for use in marketable compounds.

Pharmaceutical Companies are Investing in Potent Drug Contract Manufacturing

The increasing demand for these classes of drugs has raised 7 to 8-figure investments in high-potency active pharmaceutical ingredient contract manufacturing from leading pharmaceutical development firms worldwide.

The majority of these contract manufacturing organizations produce not only the highly potent active pharmaceutical ingredients themselves but also the ADCs (Antibody Drug Conjugates) that bond with the small molecules, helping to circulate them throughout the body and send them into targeted cells.

The Best Expertise in Highly Potent Drug CMO

Over the past few years, CMOS and pharmaceutical companies have greatly increased their investments in highly potent active pharmaceutical ingredients. CDO like AbbVie have spent millions on facilities for themselves as well as their subsidiaries.

AbbVie is one of the few potent drug contract manufacturing organizations with highly potent facilities in both Europe and North America. Here, we apply outstanding compliance records and safety, and our intensive depth of scientific expertise to protect the compounds of our clients, from lab to patient. With topnotch facilities, proven processes, and experienced people, we follow EHS standards and the highest regulatory for handling potent drugs.